Name: LXRX Balance Sheet - Lexicon Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

LXRX - Lexicon Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

LXRX Balance Sheet - Lexicon Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Cash And Short Term Investments
Cash And Equivalents	34.3	66.7	22.5	46.3	64.1	126.3	36.1	80.4	61.7	46.6	203.0	137.3	37.5	30.4	186.3	-	100.6	85.9
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	61.9	171.3	147.6	92.0	22.7	26.0	235.5	79.7	249.1	299.9	318.4	202.1	91.6	192.8	95.4	-	-
Cash And Short Term Investments	96.2	238.0	170.0	138.4	86.7	152.3	271.7	160.1	310.8	346.5	521.4	339.3	129.1	223.2	281.7
Receivables
Accounts Receivable	2.4	3.5	1.0	0.0	0.0	0.4	56.5	5.9	4.8	7.5	0.9	1.0	0.8	1.4	0.4
Current Assets
Inventory	0.3	0.2	0.4	0.0	-	0.0	4.2	4.7	1.9	0.0	-	-	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	4.6	4.6	6.5	6.1	6.0	6.1	75.8	75.9	76.3	79.3	80.7	37.4	123.3	126.1
Current Liabilities
Accounts Payable	3.1	14.8	14.4	10.4	9.2	5.5	12.2	12.1	38.8	52.9	19.7	13.1	9.7	7.7	6.0
Non-Current Liabilities
Long Term Debt	49.4	100.3	99.5	48.6	0.0	0.0	234.2	243.9	231.6	85.2	101.0	87.5	20.2	21.9	23.5	-
Common Equity
Common Stock	0.4	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.5	0.5	-
Supplementary Data
Total Debt	54.0	100.3	99.5	48.6	0.0	11.6	245.2	245.0	245.7	101.4	102.9	107.7	21.9	23.5	24.9	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	38.1	34.3	49.7	21.4	62.9	66.7	34.6	35.6	96.5	22.5	21.1	102.3	26.0	46.3	18.8

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Liabilities
Accounts Payable	3.0	3.1	3.8	5.9	10.7	14.8	14.2	12.2	8.1	14.4	12.0	10.5	10.3	10.4	9.4	7.3	9.3	9.2	8.3	8.5	4.9	5.5	11.7	29.8	18.2	12.2	20.9	10.0	13.9	17.8	51.5	50.5	66.6	57.7	52.6	43.9	41.9	52.9	41.5	28.2
Short Term Debt	0.0	4.6	-	-	42.1	0.0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	4.3	17.5	-	0.0	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	1.6	1.6	1.6	0.9	1.0	1.2	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.4	0.8
Accrued Expenses	6.9	13.2	13.6	11.5	12.9	30.4	21.8	15.7	15.3	17.2	20.2	15.6	10.1	12.8	9.0	9.5	9.6	13.0
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	9.9	20.9	21.7	34.8	110.7	45.2	36.0	27.9	23.4	31.5	32.3	26.1	20.4	23.2	18.4

Non-Current Liabilities
Long Term Debt	49.7	49.4	56.5	56.1	58.6	100.3	99.9	99.5	99.9	99.5	99.3	98.8	48.8	48.6	23.8	23.6	23.5	0.0	-	-	-	-	11.6	234.8	234.5	234.2	233.8	244.0	243.9	243.9	243.8	232.2	231.9	231.6	85.5	85.4	85.3	85.2	85.0	84.9
Operating Lease Liabilities Non-Current	6.4	6.6	6.8	4.4	4.5	4.6	4.7	4.9	5.1	5.3	5.4	-	-	5.4	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	6.4	7.2	7.5	5.2	5.3	6.9	6.7	6.0	-	5.3	-	5.5	5.5	5.4	5.4	1.0
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	66.0	77.4	85.8	96.1	174.6	152.5	142.6	133.4	128.4	136.3	137.0	130.4	74.7	77.2	47.7	41.5

Common Equity
Common Stock	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Additional Paid In Capital	2,224.0	2,129.9	2,127.0	2,123.6	2,120.4	2,117.3	2,115.9	2,113.1	2,108.5	1,862.6	1,859.3	1,855.7	1,712.6	1,709.1	1,705.6	1,608.7
Retained Earnings	(2,018.6)	(2,017.6)	(2,002.1)	(1,989.3)	(1,992.5)	(1,967.2)	(1,933.5)	(1,868.7)	(1,815.2)	(1,766.8)	(1,717.1)	(1,666.6)	(1,621.7)	(1,589.7)	(1,559.2)	(1,535.8)	(1,511.3)
Accumulated Other Comprehensive Income	(0.1)	0.0	0.0	(0.0)	0.0	0.1	0.3	(0.2)	(0.1)	0.0	(0.1)	(0.1)	(0.2)	(0.4)	(0.5)
Treasury Stock	2.8	5.2	5.2	5.2	5.2	4.6	4.6	4.6	4.6	2.9	2.9	2.9	2.9	2.1	2.1	2.1	2.1	7.5
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	202.9	107.5	120.2	129.4	123.0	146.0	178.5	240.0	288.9	93.1	139.5	186.4	88.0	117.1	144.0	70.8	92.7
Total Equity	202.9	107.5	120.2	129.4	123.0	146.0	178.5	240.0	288.9	93.1	139.5	186.4	88.0	117.1	144.0	70.8	92.7	113.6

Supplementary Data
Total Debt	49.7	54.0	56.5	56.1	100.7	100.3	99.9	99.5	99.9	99.5	99.3	98.8	48.8	48.6	23.8	23.6	23.5	0.0	11.7	11.7	11.7	11.6	20.3	245.3	245.2	245.2	245.1	245.1	245.0	245.0	244.9	245.1	245.4	245.7	100.1	100.5	101.0	101.4	101.8	102.2
Net debt	(121.0)	(42.2)	(59.4)	(82.9)	(94.1)	(137.7)	(158.5)	(210.5)	(255.7)	(70.5)	(119.2)	(158.0)	(57.1)	(89.8)	(112.4)	(38.3)	(63.0)	(86.7)
Working Capital	176.1	81.0	100.8	110.2	135.1	200.9	232.6	293.0	341.2	145.0	191.1	237.6	89.2	117.7	120.6	48.0	69.5	66.8
Book Value	202.9	107.5	120.2	129.4	123.0	146.0	178.5	240.0	288.9	93.1	139.5	186.4	88.0	117.1	144.0	70.8	92.7	113.6
Tangible Book Value	158.3	63.0	75.6	84.9	78.5	101.4	134.0	195.4	244.3	48.6	95.0	141.8	43.5	72.6	99.5	26.3	48.2

Receivables
Accounts Receivable	11.8	2.4	2.3	2.2	47.4	3.5	2.9	2.6	1.5	1.0	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	1.4	30.9	30.1	56.5	56.8	5.6	4.4	5.9	2.9	4.4	4.5	4.8	10.6	5.0	8.7	7.5	0.7	1.0

Current Assets
Inventory	0.3	0.3	0.2	0.2	0.2	0.2	0.6	0.6	0.5	0.4	0.3	0.2	-	0.0	-	-	-	-	-	-	-	-	0.0	4.0	4.1	4.2	4.5	4.3	4.6	4.7	4.8	2.1	2.1	1.9	2.1	0.8	0.2	0.0	-	-
Prepaid Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	3.3	3.0	4.1	3.7	3.3	4.5	6.7	7.7	7.0	5.1	4.3	6.1	3.3	2.5	2.8	2.9	1.9
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	186.0	101.9	122.5	145.1	245.8	246.2	268.6	320.8	364.6	176.5	223.4	263.7	109.5	140.9	139.1	64.9

Non-Current Assets
Property, Plant & Equipment Gross	4.6	4.6	4.6	4.6	4.6	4.6	4.1	3.8	-	6.5	-	-	-	-	-	-	-	-	6.2	5.9	-	6.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	2.8	2.7	2.6	2.4	2.3	2.1	2.0	1.8	4.7	4.5	4.4	4.2	4.1	4.0	5.2	5.1	5.0
Property,Plant & Equipment Net	1.8	1.9	2.0	2.1	2.3	2.5	2.1	2.0	1.8	2.0	2.1	2.2	2.2	2.1	0.9	1.0	1.1
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5	44.5
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	7.1	7.3	7.5	4.5	4.6	4.8	5.0	5.2	5.4	5.5	5.7	6.3	6.4	6.4	7.1	1.8
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	0.4	0.4	0.4	0.4	0.4	0.4	0.8	0.8	0.8	0.8	0.7	6.3	6.4	0.4	7.1	1.8	2.1
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	268.8	185.0	205.9	225.6	297.7	298.4	321.1	373.4	417.2	229.4	276.5	316.7	162.7	194.3	191.7	112.3	136.2